IFN-β-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-β-1b Therapeutic Effects in Multiple Sclerosis1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.165.1.548PMID 10861095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Real-Time Quantitative PCR

  2002cited by this paper
• Interleukin-12: amiss in MS.

  1999cited by this paper
• Two Roads Diverged: Interferon α/β– and Interleukin 12–mediated Pathways in Promoting T Cell Interferon γ Responses during Viral Infection

  1999cited by this paper
• Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

  1999cited by this paper
• Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling.

  1999cited by this paper
• Interleukin‐12: Amiss in MS

  1999cited by this paper
• Decreased interleukin‐10 and increased interleukin‐12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

  1999cited by this paper
• Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.

  1998influential reference
• Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

  1998cited by this paper
• Increased release of interleukin-12p40 in MS

  1998cited by this paper
• Interleukin-12: a cytokine at the interface of inflammation and immunity.

  1998cited by this paper
• Potent suppression of IL‐12 production from monocytes and dendritic cells during endotoxin tolerance

  1998cited by this paper
• The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

  1998cited by this paper
• Interleukin‐12 and Perforin mRNA Expression is Augmented in Blood Mononuclear Cells in Multiple Sclerosis

  1998cited by this paper
• An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease

  1998cited by this paper
• Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis.

  1998cited by this paper
• Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron® and AVONEX™

  1998cited by this paper
• Regulation of Interleukin-12 by Interleukin-10, Transforming Growth Factor-β, Tumor Necrosis Factor-α, and Interferon-γ in Human Monocytes Infected with Mycobacterium tuberculosis H37Ra

  1998cited by this paper
• Identification and Characterization of a Novel Ets-2-related Nuclear Complex Implicated in the Activation of the Human Interleukin-12 p40 Gene Promoter*

  1997cited by this paper
• Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12.

  1997cited by this paper
• Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression

  1997cited by this paper
• Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction

  1997cited by this paper
• Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma).

  1997cited by this paper
• Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4 (cid:49) T cells via CD40 ligand

  1997cited by this paper
• Mechanisms of interferon beta action in multiple sclerosis

  1997influential reference
• Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection

  1997cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

  1996cited by this paper
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

  1996cited by this paper
• Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis.

  1996cited by this paper
• Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro.

  1996cited by this paper
• The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

  1996cited by this paper
• Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99)

  1996cited by this paper
• High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590]

  1996cited by this paper
• CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

  1996cited by this paper
• Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus

  1996cited by this paper
• Regulation of interleukin 12 p40 expression through an NF-κB half-site : Murphy, T.O.et al. (1995) Mol. Cell. Biol. 15, 5258–5267

  1996cited by this paper
• Comparative Effects of Interferon-Consensus 1, Interferon-α2a, and Interferon-/βlb on HLA Expression and Lymphoproliferation: A Preclinical Model for Treatment of Multiple Sclerosis

  1996cited by this paper
• Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis

  1996cited by this paper
• A Mini-Surge on the Ryder Glacier, Greenland, Observed by Satellite Radar Interferometry

  1996cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12

  1995cited by this paper
• Through an Nf-kappa B Half-site. Regulation of Interleukin 12 P40 Expression

  1995cited by this paper
• Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

  1995cited by this paper
• Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.

  1995cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones

  1994cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

  1990cited by this paper
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

  1989cited by this paper
• Exacerbations of multiple sclerosis in patients treated with gamma interferon

  1987cited by this paper
• Exacerbations of multiple sclerosis in patients treated with gamma interferon.

  1987cited by this paper
• FORMATION OF SEROLOGICALLY REACTIVE DEXTRANS BY STREPTOCOCCI FROM SUBACUTE BACTERIAL ENDOCARDITIS

  1946cited by this paper

• Darren P. Baker, PhD A Pioneer in the Development of Pegylated Interferon-β for Clinical Use

  2023cites this paper
• Multiple sclerosis and drug discovery: A work of translation

  2021cites this paper
• Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.

  2020cites this paper
• CD 80 + and CD 86 + B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy / tropical spastic paraparesis and multiple sclerosis

  2019cites this paper
• Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis

  2019cites this paper
• Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production

  2019cites this paper
• Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis

  2018cites this paper
• Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome

  2018cites this paper
• Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.

  2017cites this paper
• A protective role of IRF3 and IRF7 signalling downstream TLRs in the development of vein graft disease via type I interferons

  2017cites this paper
• Synergetic and antagonistic effects of combined calcitriol and interferon-β treatment on cytokine production by stimulated PBMCs.

  2016cites this paper
• Interrogating Raf-1 Kinase Inhibitor Protein (RKIP) as a Novel Therapeutic Target for Modulating Inflammatory Responses

  2016cites this paper
• Mechanism of Action of Interferon Beta in Treatment of Multiple Sclerosis

  2016cites this paper
• Modulazione dell'espressione del recettore VLA4 in relazione a diverse terapie farmacologiche in pazienti affetti da sclerosi multipal

  2015cites this paper
• Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

  2015cites this paper
• CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

  2014cites this paper
• IMMUNOMODULATORY EFFECTS OF NITAZOXANIDE AND RELATED MOLECULES

  2014cites this paper
• Is T-bet a Potential Therapeutic Target in Multiple Sclerosis?

  2014cites this paper
• Suppressor of Cytokine Signaling-3 CD40 Gene Expression through Induction of IL-10 Inhibits Lipopolysaccharide-Induced

  2014cites this paper
• [Aspects of the innate immune response to intramammary Staphylococcus aureus infections in cattle].

  2014cites this paper
• possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

  2014cites this paper
• Aspectos de la respuesta inmune innata en las infecciones intramamarias causadas por Staphylococcus aureus en bovinos

  2014cites this paper
• Distinct cytokine and T helper cell profiles between patients with multiple sclerosis who had or had not received interferon‐beta

  2014cites this paper
• Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.

  2013cites this paper
• Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.

  2013cites this paper
• Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy

  2013cites this paper
• Gene Expression Pattern Characterises Development of Multiple Sclerosis

  2013cites this paper
• Human immune responses to Plasmodium falciparum infection: molecular evidence for a suboptimal THαβ and TH17 bias over ideal and effective traditional TH1 immune response

  2013cites this paper
• Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis

  2013cites this paper
• Triggered by Liver NKT Cell Activation Attenuates NK Cell-Dependent Liver Injury β Activating Immunity in the Liver. II. IFN-

  2013cites this paper
• Decoding the complexity of type I interferon to treat persistent viral infections.

  2013cites this paper
• Astrocytes modulate microglial phenotype and dendritic cell-like properties

  2012cites this paper
• Immunomodulatory functions of type I interferons

  2012cites this paper
• How type I interferons shape myeloid cell function in CNS autoimmunity

  2012cites this paper
• The Role of Glycogen Synthase Kinase 3 in Regulating IFN-β–Mediated IL-10 Production

  2011cites this paper
• T Helper Type 1/T Helper Type 17-Related Cytokines in Chronic Hepatitis C Patients before and after Interferon and Ribavirin Therapy

  2011cites this paper
• Human Immune Responses to Plasmodium falciparum infection: Molecular Evidence for a Suboptimal THαβ(TH9) and TH17 Bias over Ideal and Effective Traditional TH1 Immunity

  2011cites this paper
• Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

  2010cites this paper
• Comparative Kinetics of Escherichia coli- and Staphylococcus aureus-Specific Activation of Key Immune Pathways in Mammary Epithelial Cells Demonstrates That S. aureus Elicits a Delayed Response Dominated by Interleukin-6 (IL-6) but Not by IL-1A or Tumor Necrosis Factor Alpha

  2010cites this paper
• Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.

  2010cites this paper
• Interferon-β mechanisms of action in multiple sclerosis

  2010cites this paper
• Anti-cytokine therapeutics: history and update.

  2009cites this paper
• The role of glycogen synthase kinase 3-beta in interferon beta biology

  2009cites this paper
• Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.

  2008cites this paper
• Expression and Functional Significance of SOCS-1 and SOCS-3 in Astrocytes1

  2008cites this paper
• Type I IFN-Induced, NKT Cell-Mediated Negative Control of CD8 T Cell Priming by Dendritic Cells1

  2008cites this paper
• Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-β treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

  2008cites this paper
• SOCS-1 and SOCS-3 in Astrocytes Expression and Functional Significance of

  2008cites this paper
• Cytokines in Demyelinating Diseases

  2008cites this paper
• Effects of interferon-β on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-β treatment in patients with multiple sclerosis

  2008cites this paper
• Dendritic Cells Negative Control of CD8 T Cell Priming by Type I IFN-Induced, NKT Cell-Mediated

  2008cites this paper
• Gene expression studies in multiple sclerosis.

  2007cites this paper
• Clinical significance of glatiramer acetate antibodies

  2007cites this paper
• B-cell function in CNS inflammatory demyelinating disease: a complexity of roles and a wealth of possibilities

  2007cites this paper
• T cell-based therapies in multiple sclerosis

  2007cites this paper
• Zellspezifische Funktionen des Typ 1 Interferonrezeptors bei der experimentellen autoimmunen Enzephalomyelitis

  2007cites this paper
• Interferon beta for glomerulonephritis?

  2007cites this paper
• Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.

  2007cites this paper
• Einfluss der Typ-I-Interferone und IFN-alpha-Subtypen auf die retrovirale Friend Virus-Infektion

  2007cites this paper
• IFN‐β‐induced SOCS‐1 negatively regulates CD40 gene expression in macrophages and microglia

  2006cites this paper
• IFN- (cid:1) -induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia

  2006influential citation
• Die Bedeutung löslicher TNF-Familienmitglieder für die multiple Sklerose

  2006cites this paper
• Modulation der Chemokine IP-10 und MCP-1 und ihrer Rezeptoren CXCR3 bzw. CCR2 durch Interferon-β1a in vitro und in vivo

  2006cites this paper
• IFN-β Inhibits T Cell Activation Capacity of Central Nervous System APCs1

  2006cites this paper
• IFN-beta inhibits T cell activation capacity of central nervous system APCs.

  2006cites this paper
• IL-10 Inhibits Lipopolysaccharide-Induced CD40 Gene Expression through Induction of Suppressor of Cytokine Signaling-3

  2006cites this paper
• Suppression of Ongoing Disease in a Nonhuman Primate Model of Multiple Sclerosis by a Human-Anti-Human IL-12p40 Antibody1

  2005cites this paper
• Strategien der Gewinnung dendritischer Zellen aus humanen Monozyten zur Tumor-Immuntherapie: Vergleich von Interleukin-4 mit Interferon-alpha als Differenzierungsfaktoren

  2005cites this paper
• Seeligeriolysin O, a protein toxin of Listeria seeligeri, stimulates macrophage cytokine production via Toll-like receptors in a profile different from that induced by other bacterial ligands.

  2005cites this paper
• Sclerosis by a Human-Anti-Human IL-12 p 40 Nonhuman Primate Model of Multiple Suppression of Ongoing Disease in a

  2005cites this paper
• Multiple sclerosis: interferon-beta induces CD123+BDCA2− dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production

  2005cites this paper
• Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells1

  2005cites this paper
• Cytokines in multiple sclerosis: from bench to bedside.

  2005cites this paper
• Pharmacogenetics of autoimmune diseases: research issues in the case of Multiple Sclerosis and the role of IFN-beta.

  2005cites this paper
• Leczenie immunomodulujące stwardnienia rozsianego o wczesnym początku The immunomodulatory treatment in early onset multiple sclerosis

  2005cites this paper
• Effects of interferon-beta on the cytokine production of astrocytes.

  2005cites this paper
• Type I interferons inhibit maturation and activation of mouse Langerhans cells.

  2005cites this paper
• Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.

  2004cites this paper
• What do we know about the mechanism of action of disease-modifying treatments in MS?

  2004cites this paper
• Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naïve CD8+ T cells in the mouse

  2004cites this paper
• The role of type I interferons in non‐viral infections

  2004cites this paper
• Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination.

  2004cites this paper
• Interferons in Relapsing-Remitting Multiple Sclerosis

  2004cites this paper
• Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis.

  2003cites this paper
• Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.

  2003cites this paper
• Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

  2003cites this paper
• TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis.

  2003cites this paper
• Interferon-beta in the treatment of relapsing-remitting multiple sclerosis.

  2003cites this paper
• Interferon‐α disables dendritic cell precursors: dendritic cells derived from interferon‐α‐treated monocytes are defective in maturation and T‐cell stimulation

  2003cites this paper
• In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: Implications for MS pathogenesis

  2003cites this paper
• IFN-β Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis1

  2003cites this paper
• 20. Immunologic neuromuscular disorders.

  2003cites this paper
• This information is current as Autoimmune Encephalomyelitis Intravenous Tolerance in Experimental The Role of IL-12 in the Induction of and

  2002cites this paper
• Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.

  2002cites this paper
• The hepatic immune system.

  2002cites this paper
• Innate immune responses in viral encephalitis.

  2002cites this paper
• A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis.

  2002cites this paper
• Interferon beta in multiple sclerosis: relationship between sustained serum IgG levels and clinical outcome.

  2002cites this paper
• Type I Interferons Inhibit Interleukin-10 Production in Activated Human Monocytes and Stimulate IL-10 in T Cells: Implications for Th1-Mediated Diseases

  2002cites this paper
• Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

  2002cites this paper